Wegener's granulomatosis associated with renal cell carcinoma

Arthritis and Rheumatism

Volumn 42, Issue 4, 1999, Pages 751-756

  Tatsis, Efstratios ^a,b   Reinhold Keller, Eva ^a,b   Steindorf, Karen ^c   Feller, Alfred C ^a   Gross, Wolfgang L ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rheumaklinik Bad Bramstedt   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOBLASTIN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CARCINOMA, RENAL CELL; COMORBIDITY; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYELOBLASTIN; RETROSPECTIVE STUDIES; SERINE ENDOPEPTIDASES; SEROEPIDEMIOLOGIC STUDIES; WEGENER GRANULOMATOSIS;

EID: 0032930962     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D     Document Type: Article

References (21)

1. Fraumeni JF, Gridley G Jr, Hoover RN, Klippel JH. Incidence of cancer among men with the Felty syndrome. Ann Intern Med 1994;120:35-9.
2. Naschitz JE, Rosner I, Rozenbaum M, Elias N, Yeshurun D. Cancer-associated rheumatic disorders: clues neoplasia. Semin Arthritis Rheum 1995;24:231-41.
3. Seda H, Alarcón GS. Musculoskeletal syndromes associated with malignancies. Curr Opin Rheumatol 1995;7:48-53.
4. Kurzrock R, Cohen PR. Clinical manifestations of vasculitis in patients with solid tumors. Arch Intern Med 1994;154:334-42.
5. Edgar JDM, Rooney DP, McNamee P, McNeill TA. An association between ANCA positive renal disease and malignancy. Clin Nephrol 1993;40:22-5.
6. Araki R, Shima T, Goto H, Imoto I, Baba M, Misaki M, et al. Wegener's granulomatosis with papillary adenocarcinoma of the thyroid. Intern Med 1992;31:1065-8.
7. Mayet WJ, Hermann E, Csernok E, Knuth A, Poralla T, Gross WL, et al. A human renal cancer line as new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosis. J Immunol Methods 1991;143:57-68.
8. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
9. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
10. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 1989;111:28-40.
12. Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross WL, et al, and the EEC/BCR Group for ANCA Assay Standardization. The value of indirect immunofluorescence and solid phase techniques for ANCA detection: a report on the first phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 1993;159:1-16.
13. Csernok E, Lüdemann J, Gross WL, Bainton DF. Ultrastructural localization of proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Am J Pathol 1990;137: 1113-20.
14. Hsu SM, Raine L, Fanger M. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison of ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
15. Breslow NE, Day NE. Statistical methods in cancer research. I. IARC. No. 32:1-350. Lyon: Scientific Publications; 1980.
16. Gross WL, Csernok E. Immunodiagnostic and pathophysiological aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995;7:11-9.
17. Barret TG, Taylor DM, Thomason P, Pall A, Adu D. Environmental trigger for anti-neutrophil cytoplasmic antibodies? Lancet 1993;342:369-70.
18. Dolman KM, Gans RO, Vervaat TJ, Zevenbergen G, Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342:651-2.
19. Hartlapp V, Köster I, von Ferber L. Prevalence and distribution of malignant neoplasm in Germany: secondary data analysis of a representative sample of members of a statutory health insurance in Dortmund. Dtsch Med Wschr 1994;119:904-8.
20. Motzer RJ, Bander NH, Nanus DM. Medical progress: renal-cell carcinoma. N Engl J Med 1996;335:865-75.
21. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, et al. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:919-24.